Article thumbnail

Role of NAD(P)H Oxidase in Superoxide Generation and Endothelial Dysfunction in Goto-Kakizaki (GK) Rats as a Model of Nonobese NIDDM

By Sachin Gupte, Nazar Labinskyy, Rakhee Gupte, Anna Csiszar, Zoltan Ungvari and John G. Edwards
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2909910
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). Abnormality in fibre type distribution of soleus and plantaris muscles in nonobese diabetic Goto-Kakizaki rats.
  2. (1978). Activities of hepatic enzymes in spontaneous diabetes rats produced by selective breeding of normal Wistar rats.
  3. (2009). Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerations.
  4. (2001). Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus.
  5. (2001). beta-cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony.
  6. (2007). Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.
  7. (2002). Cyclosporin A does not block exercise-induced cardiac hypertrophy.
  8. (2001). Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate.
  9. (1999). Decreased susceptibility to lipid peroxidation of Goto-Kakizaki rats: relationship to mitochondrial antioxidant capacity.
  10. (2004). Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
  11. (2006). Diabetic cardiomyopathy: the search for a unifying hypothesis.
  12. (2004). Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats.
  13. (2002). Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state.
  14. (2007). Early adaptations to training: upregulation of alpha-myosin heavy chain gene expression.
  15. (1999). Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats.
  16. (2001). Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
  17. (2008). Endothelial function and vascular oxidative stress in long-lived GH/IGFdeficient Ames dwarf mice.
  18. (2004). Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity.
  19. (1979). Evolution of glomerular lesions in rats with spontaneous diabetes.
  20. (2008). Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats.
  21. (2007). Glucose down-regulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species.
  22. (1989). Hassid A
  23. (2003). Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.
  24. (2002). Impact of diabetes on induction of the mitochondrial permeability transition.
  25. (1997). Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
  26. (2002). Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
  27. (2000). Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency.
  28. (2003). Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.
  29. (1999). Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C.
  30. (2007). Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
  31. (2003). Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase.
  32. (2006). Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
  33. NADPH oxidase 4 is an oncoprotein localized to mitochondria.
  34. (1991). Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro.
  35. (2005). Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
  36. (2007). Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype.
  37. (2010). Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes.
  38. (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.
  39. (2008). Pathophysiological, genetic and gene expression features of a novel rodent model of the cardio-metabolic syndrome.
  40. (1982). Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies.
  41. (2001). Phenotyping of individual pancreatic islets locates genetic defects in stimulus secretion coupling to Niddm1i within the major diabetes locus in GK rats.
  42. (1976). Production of a spontaneous diabetic rats by repetition of selective breeding.
  43. (2004). Quantitative trait locus dissection in congenic strains of the Goto-Kakizaki rat identifies a region conserved with diabetes loci in human chromosome 1q.
  44. (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span.
  45. (2008). Roles of phosphatidylinositol 3-kinase-Akt and NADPH oxidase in adenosine 59-triphosphate-sensitive K+ channel function impaired by high glucose in the human artery.
  46. (2009). Subcellular localization of Nox4 and regulation in diabetes.
  47. (2009). Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH.
  48. (2009). Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.
  49. (1987). The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
  50. (2009). The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?
  51. (2005). The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.
  52. (1978). Thickening of glomerular basement membrane in spontaneously diabetic rats.
  53. (2010). Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.
  54. (2007). Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging.
  55. (2009). Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.